Replies to post #611 on Abbott Laboratories (ABT)

[aCryptoKing]

But the company’s initial forecast of providing 50,000 tests a day, starting soon, may need to await further validation. A researcher at the Cleveland Clinic, Gary Procop, MD, tested five products on 239 patient samples known to be positive for COVID-19. Abbott’s test missed 15 percent.

https://geneticliteracyproject.org/2020/04/27/at-home-coronavirus-test-how-crispr-could-change-the-way-we-search-for-covid-19/

I guess the standards are lower in Europe than in the U.S.. Wondering how ABT is going to pivot from this tech & procedure to something more reliable.

[DewDiligence]

FDA approves ABT’s IgM COVID-19 test:

https://finance.yahoo.com/news/abbott-receives-fda-emergency-authorization-130000641.html

IgM shows up earlier than IgG, and hence the IgM test is less likely to miss a true positive when someone produces antibodies in response to a recent infection.